Sponsored Research, Sales Drive Up Nanogen s Q3 Revenues | GenomeWeb

NEW YORK, Oct 31 – Nanogen said Tuesday its third quarter revenues jumped 84 percent to $3.5 million from $1.9 million, with $545,000 stemming from sales of its NanoChip Molecular Biology Workstations and NanoChip cartridges.

In third quarter 1999, Nanogen did not post any revenues from sales of its products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.